US Bancorp
MBX

US Bancorp’s MBX Biosciences MBX Stock Holding History

US Bancorp’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.48K Sell
284
-28
-9% -$952 ﹤0.01% 3415
2025
Q4 		$9.84K Sell
312
-25
-7% -$607 ﹤0.01% 3337
2025
Q3 		$5.9K Hold
337
– – ﹤0.01% 3487
2025
Q2 		$3.85K Buy
337
+7
+2% +$71 ﹤0.01% 3714
2025
Q1 		$2.44K Buy
+330
New +$3.49K ﹤0.01% 3832

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

US Bancorp's MBX Position: Q1 2026 in Review

US Bancorp reduced its MBX Biosciences (MBX) stake by 9% in Q1 2026, selling an estimated $952 and leaving 284 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.

US Bancorp first reported a position in MBX in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.84K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • US Bancorp held 284 shares of MBX Biosciences worth $8.48K as of Q1 2026.
  • US Bancorp sold 28 MBX Biosciences shares in Q1 2026, an estimated $952.
  • MBX Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3415 holding.
  • US Bancorp first reported a position in MBX Biosciences in Q1 2025 and has held it in 5 quarters since.
  • US Bancorp's MBX Biosciences position peaked at $9.84K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.